Bowel Cleansing
2
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Ferring PharmaceuticalsArgentina - Buenos Aires
2 programs1
PICOPREPPhase 31 trial
Sodium Picosulfate, Magnesium Oxide and Citric AcidN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
IpsenEziclen
Ferring PharmaceuticalsPICOPREP
Ferring PharmaceuticalsSodium Picosulfate, Magnesium Oxide and Citric Acid
IpsenEziclen®/Izinova®
Clinical Trials (4)
Total enrollment: 3,084 patients across 4 trials
Efficacy, Safety and Tolerability of Eziclen in Adult Subjects Undergoing Colonoscopy
Start: Mar 2015Est. completion: Dec 2015296 patients
Phase 3Completed
A Trial Comparing the PICOPREP Tailored Dosing Schedule to the PICOPREP Day-before Dosing Schedule for Colon Cleansing in Preparation for Colonoscopy
Start: Nov 2014Est. completion: Jun 2015204 patients
Phase 3Completed
Drug Use-Results Survey on Picoprep® Combination Powder
Start: Aug 2017Est. completion: Dec 20211,298 patients
N/ACompleted
Eziclen Drug Utilisation in Real Life Setting
Start: Oct 2015Est. completion: Apr 20171,286 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space